Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Completed · Phase 3 · Has a placebo group

Conditions studied: Osteoporosis, Osteoporosis, Age-Related, Osteoporosis Localized to Spine, Age Related Osteoporosis, Osteoporosis Senile, Osteoporosis of Vertebrae

In brief

A 12-month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.

Key facts

Study ID
NCT03512262
Run by
Radius Health, Inc.
People needed
228
Starts
2018-05-03
Expected to finish
2021-09-08
Last updated by the study team
2023-04-07

Who can join

Age: 40 and older, up to 85. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.